Page 180 - Livre électronique du congrès des RFTP 2022
P. 180

P110

              IMPACT OF OBESITY ON THE INTRA-HOSPITAL EVOLUTION
              OF PATIENTS WITH SARS-COV-2 PNEUMONIA

              E. BEN JEMIA, S. RJEB, N. KHALFALLAH, H. OUERTANI, J. BEN AMAR, H. ZAIBI, H. AOUINA
              CHARLES NICOLLE HOSPITAL OF TUNIS


              BACKGROUND : Obesity has been widely reported to be associated with the disease
              progression of SARS-CoV-2 pneumonia and research into this association has yielded
              conflicting results. Therefore, we examined the impact of obesity on the intra-hospital
              evolution of patients with SARS-COV-2 pneumonia.
              METHODS : A retrospective and comparative study was conducted for 6 months in
              Charles Nicolle Hospital of Tunis. Patients with confirmed SARS-COV-2 moderate to
              severe pneumonia were included. We calculated body mass index (BMI, kg/m2) and
              we identified 2 groups: G1: obese patients (BMI ≥ 30 ; n=66) and non-obese patients
              (BMI<30 ; n=25).

              RESULTS : We included 91 patients with sex ratio at 1.1, an average age at 61± 13 years
              [22-96 years] and BMI’ mean at 28 ± 5 kg/m2 [21-43 Kg/ m2]. Obese patients were
              younger 61years vs 68 years; p=0,02) with BMI mean at 31.5 kg/m2. Comorbidities
              didn’t differ between groups (p=0,8). Severity of acute infection was similar in both
              groups (p˃0.05)

              Obesity was associated with poor outcomes (OR = 0.667, 95% CI [0.240–1.849]). In fact,
              hospitalization in intensive care unit was necessary for 14 obese patients G1 vs 6 non-
              obese patients; p=0,42. Mortality was higher in obese patients (G1: 13 patients vs G2 :7
              patients; p=0,5). Hospital stay was similar in both groups (12 days vs 13 days; p=0,54).

              CONCLUSION  :  According to the literature, obesity is responsible for poor
              intrahospital evolution during SARS-COV2 acute infection.






















                                                                                                 Page | 173
   175   176   177   178   179   180   181   182   183   184   185